ArticleScientific reports2025
Anticancer activity of nanoemulsion formulation of Chicorium intybus L. seed extract on human breast cancer cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms and Therapeutic Targets of Botanicals Derived from Asteraceae Plant Species.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cichorium intybus L. is a renowned plant in traditional systems of medicine. It has been used in the treatment of various chronic ailments. The phytometabolites found in C. intybus have shown promising anticancer activity in vivo and clinical trials and positive cytotoxic effects in vitro. These findings suggest that C. intybus metabolites may be used in cancer treatment. Breast cancer is caused by aberrant breast cell proliferation and develops into tumours. All across the world, breast cancer affects women at any age after adolescence. However, its prevalence rises with age. In the present study, the aqueous titration method has been used to formulate a highly stable C. intybus extract nanoemulsion (CISNE). The optimized nanoemulsion with particle size of 218.7 nm and maximium drug release efficiency in 24 h was prepared. The CISNE showed good cytotoxic potential against MDA-MB-231 cell line. It also significantly induced apoptotic morphological alterations in cells. Moreover, CISNE induced apoptosis in MDA-MB-231 cells by loss of mitochondrial membrane potential (ΔΨm) which was associated with the accumulation of reactive oxygen species (ROS) and G2/M cell cycle arrests. This study demonstrated that the development of CISNE could be an efficient carrier for drug delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.